Lawrence John H III 4
4 · PORTOLA PHARMACEUTICALS INC · Filed Dec 1, 2017
Insider Transaction Report
Form 4
Lawrence John H III
SVP, Chief Medical Officer
Transactions
- Award
Common Stock
2017-11-30+5,000→ 5,000 total - Award
Stock Option (Right to Buy)
2017-11-30+125,000→ 125,000 totalExercise: $50.75Exp: 2027-11-29→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]Grant of Restricted Stock Units ("RSU") in consideration of services rendered. The RSU vests annually over three years commencing on March 1, 2019, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shall vest as follows: 25% of the shares shall vest one year from the Vesting Commencement Date of November 6, 2017, and the remaining shares shall vest ratably over the next 36 months.